Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NRC · against 423 other Healthcare companies of similar size
Ranked #330 of 424 · scores higher than 21% of peers
Bars: peers in each 10-point band of the growth score70 peers with a growth score of 10–19, including NRC · Click a bar to see the companies
Mainly because of its earnings per share growth, 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | NRC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 437 reported | -0.2% | 3.0% | 41% | 33% | |
| Earnings per share growthHigher is better · 220 reported | -65.9% | 3.9% | 9% | 33% | |
| 3-year revenue growthHigher is better · 414 reported | -1.9% | 3.0% | 35% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 330 | 5.9B CNY (≈$830M) | 15 | 60 | |
| 330 | 6.1B HKD (≈$786M) | 15 | 52 | |
| 330 | 3.5B CNY (≈$487M) | 15 | 25 | |
| 330 | 26.5B INR (≈$317M) | 15 | 34 | |
| 330 | 532M USD | 15 | 34 | |
| 336 | 6.3B CNY (≈$881M) | 14 | 44 | |
| 336 | 2.0B CNY (≈$278M) | 14 | 46 | |
| 336 | 4.2B CNY (≈$590M) | 14 | 33 | |
| 336 | 15.7B TWD (≈$485M) | 14 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score